xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

705

Orlandi et al.

1531. Amar YG, Frenkiel S, Sobol SE. Outcome analysis of endo scopic sinus surgery for chronic sinusitis in patients having Samter’s triad. J Otolaryngol . 2000;29(1):7-12. 1532. Chang HS, Park JS, Shin HR, Park BL, Shin HD, Park CS. Asso ciation analysis of FABP1 gene polymorphisms with aspirin exacerbated respiratory disease in asthma. Exp Lung Res . 2014;40(10):485-494. 1533. Snidvongs K, Kalish L, Sacks R, Sivasubramaniam R, Cope D, Harvey RJ. Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusi tis: systematic review and meta-analysis. Am J Rhinol Allergy . 2013;27(3):221-233. 1534. Head K, Snidvongs K, Glew S, et al. Saline irrigation for aller gic rhinitis. Cochrane Database Syst Rev . 2018;6(6):Cd012597. 1535. Snidvongs K, Lam M, Sacks R, et al. Structured histopathol ogy profiling of chronic rhinosinusitis in routine practice. Int Forum Allergy Rhinol . 2012;2(5):376-385. 1536. Hermelingmeier KE, Weber RK, Hellmich M, Heubach CP, Mösges R. Nasal irrigation as an adjunctive treatment in aller gic rhinitis: a systematic review and meta-analysis. AmJRhi nol Allergy . 2012;26(5):e119-e125. 1537. Elkins MR, Bye PT. Mechanisms and applications of hyper tonic saline. JRSocMed . 2011;104(1_suppl):2-5. 1538. Bonnomet A, Luczka E, Coraux C, de Gabory L. Non-diluted seawater enhances nasal ciliary beat frequency and wound repair speed compared to diluted seawater and normal saline. Int Forum Allergy Rhinol . 2016;6(10):1062-1068. 1539. Zeng M, Wang H, Liao B, et al. Comparison of efficacy of fluticasone propionate versus clarithromycin for postopera tive treatment of different phenotypic chronic rhinosinusitis: a randomized controlled trial. Rhinology . 2019;57(2):101-109. 1540. Xu Z, Luo X, Shi J, Lai Y. The effect of budesonide repulses nasal drop for the short-course treatment for chronic rhinos inusitis with nasal polyps: a randomized controlled clinical trial. Allergy: European J Allergy Clin Immunol . 2019;74 (Suppl 106):329. 1541. Seiberling KA, Kidd SC, Kim GH, Church CA. Efficacy of dex amethasone versus fluticasone nasal sprays in postoperative patients with chronic rhinosinusitis with nasal polyps. AmJ Rhinol Allergy . 2019;33(5):478-482. 1542. Khan AR, Arif MAU. Mometasone furoate intra nasal spray for the treatment of bilateral nasal polyposis. J Med Sci (Peshawar) . 2019;27(3):203-209. 1543. Zhou B, He G, Liang J, et al. Mometasone furoate nasal spray in the treatment of nasal polyposis in Chinese patients: a double-blind, randomized, placebo-controlled trial. IntForum Allergy Rhinol . 2016;6(1):88-94. 1544. Schenkel EJ, Peters AT, Messina JC, Sacks HJ, Mahmoud RA. Evidence for twice-daily nasal steroids versus once daily for treatment of chronic rhinosinusitis with nasal polyps. JAllergy Clin Immunol . 2019;143 (2 Suppl):AB283. 1545. Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Bur ton MJ. Intranasal steroids versus placebo or no interven tion for chronic rhinosinusitis. Cochrane Database Syst Rev . 2016;4:CD011996. 1546. Mygind N, Pedersen CB, Prytz S, Sorensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy . 1975;5(2):159-164.

nosinusitis: systematic review of the literature and meta analysis. J Allergy Clin Immunol . 2015;136(6):1523-1531. 1514. Tran Khai Hoan N, Karmochkine M, Laccourreye O, Bonfils P. Nasal polyposis and immunoglobulin-G subclass deficiency. Eur Ann Otorhinolaryngol Head Neck Dis . 2014;131(3):171-175. 1515. Baraniuk JN, Maibach H. Pathophysiological classification of chronic rhinosinusitis. RespirRes . 2005;6:149. 1516. Samter M, Beers RF, Jr. Intolerance to aspirin. Clinical stud ies and consideration of its pathogenesis. Ann Intern Med . 1968;68(5):975-983. 1517. Gosepath J, Schafer D, Mann WJ. Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day. Laryn gorhinootologie . 2002;81(10):732-738. 1518. Laidlaw TM, Boyce JA. Aspirin-exacerbated respiratory disease–new prime suspects. N Engl J Med . 2016;374(5):484 488. 1519. Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N ERD)-a EAACI position paper. Allergy . 2019;74(1):28-39. 1520. Baker TW, Quinn JM. Aspirin therapy in aspirin-exacerbated respiratory disease: a risk-benefit analysis for the practicing allergist. Allergy Asthma Proc . 2011;32(5):335-340. 1521. Rajan JP, Wineinger NE, Stevenson DD, White AA. Preva lence of aspirin-exacerbated respiratory disease among asth matic patients: a meta-analysis of the literature. J Allergy Clin Immunol . 2015;135(3):676-681.e671. 1522. Roland LT, Wang H, Mehta CC, et al. Longitudinal progres sion of aspirin-exacerbated respiratory disease: analysis of a national insurance claims database. Int Forum Allergy Rhinol . 2019;9(12):1420-1423. 1523. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol . 2003;111(5):913-921; quiz 922. 1524. Cahill KN, Boyce JA. Aspirin-exacerbated respiratory disease: mediators and mechanisms of a clinical disease. J Allergy Clin Immunol . 2017;139(3):764-766. 1525. Choi JH, Kim MA, Park HS. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease. Curr Opin Allergy Clin Immunol . 2014;14(1):1-6. 1526. Kaldenbach T, Schafer D, Gosepath J, Bittinger F, Klimek L, Mann WJ. Significance of eosinophilic granulocytes in rela tion to allergy and aspirin intolerance in patients with sinusi tis polyposa. Laryngorhinootologie . 1999;78(8):429-434. 1527. Park SM, Park JS, Park HS, Park CS. Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachido nate pathways. Allergy Asthma Immunol Res . 2013;5(5):258 276. 1528. Losol P, Kim SH, Shin YS, Ye YM, Park HS. A genetic effect of IL-5 receptor alpha polymorphism in patients with aspirin exacerbated respiratory disease. ExpMolMed . 2013;45:e14. 1529. Laidlaw TM, Cutler AJ, Kidder MS, et al. Prostaglandin E2 resistance in granulocytes from patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol . 2014;133(6):1692-1701.e1693. 1530. Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revi sion rates after endoscopic sinus surgery: a recurrence analy sis. Ann Otol Rhinol Laryngol . 2011;120(3):162-166.